Go Pro
→ ALERT: Drop these 5 stocks before the market opens tomorrow! (From Weiss Ratings) (Ad)tc pixel Free SBFMW Stock Alerts

Sunshine Biopharma (SBFMW) Competitors

Sunshine Biopharma logo
$0.04 -0.01 (-12.82%)
As of 09:30 AM Eastern
This is a fair market value price provided by Massive. Learn more.
Compare

SBFMW vs. SXTPW, BFRIW, CALA, CINGW, and CMRAW

Should you buy Sunshine Biopharma stock or one of its competitors? Sunshine Biopharma's main competitors and comparable companies include 60 Degrees Pharmaceuticals (SXTPW), Biofrontera (BFRIW), Calithera Biosciences (CALA), Cingulate (CINGW), and Comera Life Sciences (CMRAW). Companies are selected based on similarities in market, industry, and size. These companies are all part of the "pharmaceuticals" industry.

How does Sunshine Biopharma compare to 60 Degrees Pharmaceuticals?

60 Degrees Pharmaceuticals (NASDAQ:SXTPW) and Sunshine Biopharma (NASDAQ:SBFMW) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their risk, analyst recommendations, earnings, valuation, institutional ownership, dividends, media sentiment and profitability.

In the previous week, 60 Degrees Pharmaceuticals had 1 more articles in the media than Sunshine Biopharma. MarketBeat recorded 2 mentions for 60 Degrees Pharmaceuticals and 1 mentions for Sunshine Biopharma. 60 Degrees Pharmaceuticals' average media sentiment score of 1.93 beat Sunshine Biopharma's score of 1.92 indicating that 60 Degrees Pharmaceuticals is being referred to more favorably in the media.

Company Overall Sentiment
60 Degrees Pharmaceuticals Very Positive
Sunshine Biopharma Very Positive

Company Net Margins Return on Equity Return on Assets
60 Degrees PharmaceuticalsN/A N/A N/A
Sunshine Biopharma N/A N/A N/A

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
60 Degrees Pharmaceuticals$1.00MN/AN/AN/AN/A
Sunshine Biopharma$35.49MN/AN/AN/AN/A

Summary

60 Degrees Pharmaceuticals beats Sunshine Biopharma on 2 of the 3 factors compared between the two stocks.

How does Sunshine Biopharma compare to Biofrontera?

Sunshine Biopharma (NASDAQ:SBFMW) and Biofrontera (NASDAQ:BFRIW) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their dividends, institutional ownership, analyst recommendations, valuation, media sentiment, profitability, earnings and risk.

Company Net Margins Return on Equity Return on Assets
Sunshine BiopharmaN/A N/A N/A
Biofrontera N/A N/A N/A

In the previous week, Biofrontera had 2 more articles in the media than Sunshine Biopharma. MarketBeat recorded 3 mentions for Biofrontera and 1 mentions for Sunshine Biopharma. Sunshine Biopharma's average media sentiment score of 1.92 beat Biofrontera's score of 0.96 indicating that Sunshine Biopharma is being referred to more favorably in the media.

Company Overall Sentiment
Sunshine Biopharma Very Positive
Biofrontera Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sunshine Biopharma$35.49MN/AN/AN/AN/A
Biofrontera$43.20MN/AN/AN/AN/A

Summary

Biofrontera beats Sunshine Biopharma on 2 of the 3 factors compared between the two stocks.

How does Sunshine Biopharma compare to Calithera Biosciences?

Sunshine Biopharma (NASDAQ:SBFMW) and Calithera Biosciences (NASDAQ:CALA) are both healthcare companies, but which is the superior stock? We will compare the two businesses based on the strength of their analyst recommendations, institutional ownership, dividends, risk, valuation, profitability, earnings and media sentiment.

In the previous week, Sunshine Biopharma and Sunshine Biopharma both had 1 articles in the media. Sunshine Biopharma's average media sentiment score of 1.92 beat Calithera Biosciences' score of 0.00 indicating that Sunshine Biopharma is being referred to more favorably in the media.

Company Overall Sentiment
Sunshine Biopharma Very Positive
Calithera Biosciences Neutral

Sunshine Biopharma has higher revenue and earnings than Calithera Biosciences.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sunshine Biopharma$35.49MN/AN/AN/AN/A
Calithera BiosciencesN/AN/A-$39.65MN/AN/A

Company Net Margins Return on Equity Return on Assets
Sunshine BiopharmaN/A N/A N/A
Calithera Biosciences N/A N/A N/A

Summary

Sunshine Biopharma beats Calithera Biosciences on 2 of the 2 factors compared between the two stocks.

How does Sunshine Biopharma compare to Cingulate?

Sunshine Biopharma (NASDAQ:SBFMW) and Cingulate (NASDAQ:CINGW) are both healthcare companies, but which is the better stock? We will contrast the two businesses based on the strength of their valuation, dividends, earnings, risk, profitability, analyst recommendations, institutional ownership and media sentiment.

In the previous week, Cingulate had 1 more articles in the media than Sunshine Biopharma. MarketBeat recorded 2 mentions for Cingulate and 1 mentions for Sunshine Biopharma. Sunshine Biopharma's average media sentiment score of 1.92 beat Cingulate's score of 1.44 indicating that Sunshine Biopharma is being referred to more favorably in the media.

Company Overall Sentiment
Sunshine Biopharma Very Positive
Cingulate Positive

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sunshine Biopharma$35.49MN/AN/AN/AN/A
CingulateN/AN/AN/AN/AN/A

Company Net Margins Return on Equity Return on Assets
Sunshine BiopharmaN/A N/A N/A
Cingulate N/A N/A N/A

Summary

Sunshine Biopharma beats Cingulate on 2 of the 3 factors compared between the two stocks.

How does Sunshine Biopharma compare to Comera Life Sciences?

Sunshine Biopharma (NASDAQ:SBFMW) and Comera Life Sciences (NASDAQ:CMRAW) are both healthcare companies, but which is the better stock? We will contrast the two companies based on the strength of their valuation, risk, earnings, institutional ownership, media sentiment, profitability, dividends and analyst recommendations.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
Sunshine Biopharma$35.49MN/AN/AN/AN/A
Comera Life Sciences$1.00MN/AN/AN/AN/A

In the previous week, Sunshine Biopharma had 1 more articles in the media than Comera Life Sciences. MarketBeat recorded 1 mentions for Sunshine Biopharma and 0 mentions for Comera Life Sciences. Sunshine Biopharma's average media sentiment score of 1.92 beat Comera Life Sciences' score of 0.00 indicating that Sunshine Biopharma is being referred to more favorably in the media.

Company Overall Sentiment
Sunshine Biopharma Very Positive
Comera Life Sciences Neutral

Company Net Margins Return on Equity Return on Assets
Sunshine BiopharmaN/A N/A N/A
Comera Life Sciences N/A N/A N/A

Summary

Sunshine Biopharma beats Comera Life Sciences on 3 of the 3 factors compared between the two stocks.

Get Sunshine Biopharma News Delivered to You Automatically

Sign up to receive the latest news and ratings for SBFMW and its competitors with MarketBeat's FREE daily newsletter.

Subscribe Now
SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

SBFMW vs. The Competition

Export
MetricSunshine BiopharmaPharmaceuticals IndustryHealthcare SectorNASDAQ Exchange
Market CapN/A$11.83B$7.03B$13.06B
Dividend YieldN/A2.69%2.56%10.62%
P/E RatioN/A779.61270.8525.39
Price / SalesN/A747.83597.9088.46
Price / CashN/A15.0328.8738.47
Price / BookN/A10.4011.096.51
Net IncomeN/A$2.78B$3.45B$347.22M
7 Day PerformanceN/A0.15%0.74%1.51%
1 Month PerformanceN/A0.04%2.15%2.74%
1 Year PerformanceN/A145.28%63.00%21.07%

Sunshine Biopharma Competitors List

Export
CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
SBFMW
Sunshine Biopharma
N/A$0.04
-12.8%		N/A-77.3%$0.00$35.49MN/A3
SXTPW
60 Degrees Pharmaceuticals
N/A$0.04
+39.2%		N/AN/A$0.00$1.00MN/A2
BFRIW
Biofrontera
N/A$0.03
+27.6%		N/A-75.2%$0.00$43.20MN/A70
CALA
Calithera Biosciences
N/AN/AN/AN/A$0.00N/AN/A60
CINGW
Cingulate
N/A$0.01
+9.7%		N/A-84.4%$0.00N/AN/A20

Related Companies and Tools

Related Companies
Top 10 Stock Comparisons

This page (NASDAQ:SBFMW) was last updated on 8/17/2026 by MarketBeat.com Staff.
From Our Partners
ALERT: Drop these 5 stocks before the market opens tomorrow!
The Wall Street Journal is already raising the alarm about a potential market crash, and Weiss Ratings researc...
Weiss Ratings | Sponsoredtc pixel
Louis Navellier: My #1 AI stock for 2026 (name & ticker inside)
Louis Navellier's Stock Grader system helped him flag Nvidia before its 82,000% run and has identified the top...
InvestorPlace | Sponsoredtc pixel
Ready to give options a try? Your first trade (Ticker included) -INSIDE
Tired of trying tactic after tactic when it comes to options trades... only to be met with market noise and st...
Base Camp Trading | Sponsoredtc pixel
They didn't warn anyone in 1971. This time someone is warning you.
On August 15, 1971, Nixon interrupted prime-time television and ended the gold standard in 15 minutes - no deb...
Reagan Gold Group | Sponsoredtc pixel
Iran War Shock: What I Was Told In That Private Meeting
You’re Being LIED To About The Iran War Forget EVERYTHING you’ve heard about the Iran war. Especially th...
Banyan Hill Publishing | Sponsoredtc pixel
Small Colorado Company (Backed by Sam Altman) Could Save U.S. Power Grid
A small Colorado company has secured rights to technology that could prevent the U.S. public power grid from c...
Altimetry | Sponsoredtc pixel
Buy this stock today
Marc Chaikin, founder of Chaikin Analytics, is sharing a strategy he calls 'Sell This, Buy That' - a way to mo...
Chaikin Analytics | Sponsoredtc pixel
CODE RED: AI Meltdown Imminent?
After correctly predicting the 2008 and 2020 stock market meltdowns, I believe this AI company is about to tri...
Paradigm Press | Sponsoredtc pixel